Global Head, Janssen Human Microbiome Institute
Microbiome Futures is a landmark event that will document the future of microbiome research and commercialisation.
The live event, on May 23, will be the culmination of a thorough research process during which the working group will be gathering input from a global pool of stakeholders in the microbiome space. They will come prepared, having researched and discussed issues from the science of moving from correlation to causation to practical solutions to data and regulatory hurdles.
The main format will be a panel discussion, moderated by Susan Jones, Senior Editor at Nature Biotechnology and Gaspar Taroncher-Oldenburg, consultant-in-residence for Global Engage.
Combining the summary and analysis of the event’s discussions, the working group’s feedback, and the KOLs’ input, it will be published in Nature Biotechnology as the white paper: Roadmap for Microbiome Translation.
The unique opportunity to steer the panel’s white paper before publication.
Join a select group of leading scientists, business executives, investors and stakeholders to collaboratively discuss the future of microbiome translation.
A panel of experts will lead discussions with the audience in a unique forum to create and publish a roadmap for microbiome translation.
Quay Pharma are proud sponsors of the gala dinner
The evening before the live event, join a networking dinner with the panel and distinguished guests in the beautiful library of the New York Academy of Medicine.
Includes a drinks reception on arrival with hors d’oeuvres and a full 3-course sit-down dinner with your peers.
Keynote address by:
Dan R. Littman
Helen L. and Martin S. Kimmel Professor of Molecular Immunology, Department of Pathology
Professor, Department of Microbiology